Skip to content

Clinical study of acupoint catgut embedding for the treatment of postinfectious cough

Clinical study of acupoint catgut embedding for the treatment of postinfectious cough

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000299
Enrollment
Unknown
Registered
2024-08-26
Start date
2024-08-30
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postinfectious cough

Interventions

control group:Non-point shallow thorn

Sponsors

Beijing Hospital of TCM Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meet the Western medical diagnostic criteria for cough after infection; (2) Age 18-70 years old, male or female; (3) The subject knows and signs the informed consent; (4) Those who have never received acupoint catgut embedding treatment

Exclusion criteria

Exclusion criteria: (1) Body temperature (axillary temperature) =37.0?; (2) Known or suspected diseases associated with the diagnosis of cough, such as allergic rhinitis, sinusitis, gastroesophageal reflux disease, cough variant asthma, eosinophilic bronchitis, chronic obstructive pulmonary disease, acute onset of chronic bronchitis, bronchial asthma, bronchiectasis, tuberculosis, pulmonary interstitial fibrosis, lung cancer, etc.; (3) Complicated with serious primary diseases such as cardiovascular and cerebrovascular, liver, kidney and hematopoietic system and other organic diseases such as tumors; (4) the combination of language or hearing impairment, intellectual disability, serious mental illness and other conditions can not cooperate; (5) Pregnant and lactating women, those who have fertility requirements in the past six months; (6) Regular cough related treatment (such as angiotensin-converting enzyme inhibitors); (7) Those who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
LCQ;

Secondary

MeasureTime frame
cough evaluation test(CET);Cough remission time and resolution time;vas;TCM symptom score;

Countries

China

Contacts

Public ContactLI Bin

Beijing Hospital of TCM Affiliated to Capital Medical University

libin@bjzhongyi.com010-52176644

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026